Literature DB >> 1294755

Articular histoplasmosis.

R O Darouiche1, R M Cadle, G J Zenon, M F Weinert, R J Hamill, M D Lidsky.   

Abstract

Rheumatic manifestations of histoplasmosis are uncommon. Polyarthritis or arthralgias may occur as a part of a sensitization process in primary acute histoplasmosis. Infectious arthritis may accompany disseminated histoplasmosis or occur as solitary monoarthritis. Treatment of the latter traditionally consists of surgical excision followed by amphotericin B. Reports of clinical experience with the newer triazole compounds in treating articular histoplasmosis are lacking. We describe a patient with solitary monoarticular histoplasmosis of the knee who was successfully treated with oral fluconazole and required no surgical intervention. Specific issues that pertain to clinical presentation and management of articular histoplasmosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294755

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Articular presentation of disseminated histoplasmosis.

Authors:  Debajit Sen; Jonathan Birns; Anisur Rahman
Journal:  Clin Rheumatol       Date:  2006-05-25       Impact factor: 2.980

Review 2.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Rheumatologic manifestations of histoplasmosis: a review.

Authors:  Travis C Sizemore
Journal:  Rheumatol Int       Date:  2013-07-09       Impact factor: 2.631

4.  Tenosynovitis of the wrist and thumb and carpal tunnel syndrome caused by Histoplasma capsulatum: case report and review of the literature.

Authors:  Mark A Vitale; Anja C Roden; Marco Rizzo
Journal:  Hand (N Y)       Date:  2015-03

Review 5.  Synovitis due to Histoplasma capsulatum: a case series and literature review.

Authors:  Yan Li; Florentina Berianu; Lisa Brumble; Kenneth T Calamia
Journal:  Rheumatol Int       Date:  2021-06-23       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.